Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ARICEPT FLAS 10 mg COMPRIMIDOS BUCODISPERSBLES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ARICEPT FLAS 10 mg COMPRIMIDOS BUCODISPERSBLES

Approved

STANDARD

ARICEPT FLAS 10 mg COMPRIMIDOS BUCODISPERSBLES

Eisai S.A.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 26, 2021
Approval ID: 29e4a2116c91b2dd
Company: Eisai S.A.S.
Type: Standard

Approval Details

Approval Id: 29e4a2116c91b2dd
Drug Cima Aemps Name: ARICEPT FLAS 10 mg COMPRIMIDOS BUCODISPERSBLES
Register Number: 3400937306447
Holder Company Name: Eisai S.A.S.
Marketing Company Name: Melyfarma S.L.
Authorization Date: 2021-03-26
Dosage Form: COMPRIMIDO BUCODISPERSABLE
Dose: 10 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Eisai S.A.S.

Active Ingredients

DONEPEZILO HIDROCLORURO

10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 26, 2021

Approval ID

29e4a2116c91b2dd

Type

Standard

Back to CIMA-AEMPS Approvals